Cover Image

Facilitators and barriers to implementing successful exclusion among children with shiga toxin-producing Escherichia coli: a qualitative analysis of public health case management records

Abstract Background Shiga toxin-producing Escherichia coli (STEC) infections are a significant public health concern as they can cause serious illness and outbreaks. In England, STEC incidence is highest among children and guidance recommends that children under six diagnosed with STEC are excluded...

Full description

Saved in:

Bibliographic Details
Main Authors:	Amoolya Vusirikala (Author), Yanshi (Author), Charlotte Robin (Author), Sam Rowell (Author), Girija Dabke (Author), Georgina Fox (Author), Jade Bell (Author), Rohini Manuel (Author), Claire Jenkins (Author), Nicola K Love (Author), Noel McCarthy (Author), Dana Sumilo (Author), Sooria Balasegaram (Author)
Format:	Book
Published:	BMC, 2024-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparative phenotypic characterization of hybrid Shiga toxin-producing / uropathogenic Escherichia coli, canonical uropathogenic and Shiga toxin-producing Escherichia coli
by: Noble Selasi Gati, et al.
Published: (2021)

Epidemiology of Shiga toxin producing <it>Escherichia coli </it>in Australia, 2000-2010
by: Vally Hassan, et al.
Published: (2012)

Genomic analysis of Shiga toxin-producing escherichia coli from patients and food handlers
by: H. Baba, et al.
Published: (2020)

Shiga toxin-producing Escherichia coli in human, cattle and foods. Strategies for detection and control
by: Nora Lia Padola
Published: (2014)

Application of Bacteriophages on Shiga Toxin-Producing <i>Escherichia coli</i> (STEC) Biofilm
by: Nicola Mangieri, et al.
Published: (2021)

Escherichia coli strains producing a novel Shiga toxin 2 subtype circulate in China
by: Xi Yang, et al.
Published: (2020)

Diminazene aceturate: an antibacterial agent for Shiga-toxin-producing Escherichia coli O157:H7
by: Wu SY, et al.
Published: (2016)

Anti-tumor activity of Escherichia coli Shiga toxin A subunit delivered by SF9 insect cells
by: Mana Oloomi, et al.
Published: (2018)

Prevalence of Shiga Toxin-Producing Escherichia coli in diarrheal patients in Faisalabad region of Pakistan as determined by multiplex PCR
by: Mashkoor Mohsin,1 Arshad Hussain,2 Muhammad Asghar Butt,2 Saira Bashir,1 Ayesha Tariq,1 Shoaib Babar,2 Aamir Ali,1 Asma Haque,1 Yasra Sarwar,1 and Abdul Haque1
Published: (2007)

Whole genome sequencing to characterize shiga toxin-producing Escherichia coli O26 in a public health setting
by: Baha Abdalhamid, et al.
Published: (2019)

Down-Regulation of Renal Klotho Expression by Shiga Toxin 2
by: Martina Feger, et al.
Published: (2014)

Treatment of Shiga-Toxin Hus with Severe Neurologic Features with Eculizumab
by: Jacob H. Umscheid, et al.
Published: (2021)

Chemokine Expression in Human Astrocytes in Response to Shiga Toxin 2
by: Naomi Kioka, et al.
Published: (2012)

OMV-based vaccine formulations against Shiga toxin producing Escherichia coli strains are both protective in mice and immunogenic in calves
by: Matias Fingermann, et al.
Published: (2018)

Prevalence and molecular characterization of Shiga toxin-producing Escherichia coli isolates from human and sheep in Al-Madinah Al-Munawarah
by: Eman Fathi Sharaf, et al.

Inhibition of Shiga toxin-converting bacteriophage development by novel antioxidant compounds
by: Sylwia Bloch, et al.
Published: (2018)

Atypical Presentation of Shiga Toxin Haemolytic Uremic Syndrome (STEC-HUS)
by: Inês Marques, et al.
Published: (2022)

Characterization of a Lytic Bacteriophage as an Antimicrobial Agent for Biocontrol of Shiga Toxin-Producing <i>Escherichia coli</i> O145 Strains
by: Yen-Te Liao, et al.
Published: (2019)

Steroid Pulse Therapy for Severe Central Nervous System Involvement in Shiga Toxin-Producing Escherichia coli-Related Hemolytic Uremic Syndrome
by: Chiara Rosazza, et al.
Published: (2021)

Antimicrobial Resistance of Non-O157 Shiga Toxin-Producing <i>Escherichia coli</i> Isolated from Humans and Domestic Animals
by: Yanyu Pan, et al.
Published: (2021)

DNA fingerprinting of Shiga-toxin producing <it>Escherichia coli </it>O157 based on Multiple-Locus Variable-Number Tandem-Repeats Analysis (MLVA)
by: Vardund Traute, et al.
Published: (2003)

Activity of Bacteriophage and Complex Tannins against Biofilm-Forming Shiga Toxin-Producing <i>Escherichia coli</i> from Canada and South Africa
by: Emmanuel W. Bumunang, et al.
Published: (2020)

Diarrheagenic <i>E. coli</i> in hospitalized patients: Special reference to Shiga-like toxin producing <i> <i>Escherichia</i> coli</i>
by: Lanjewar Mrudul, et al.
Published: (2010)

Synergistic Effects of Bacteriophage vB_Eco4-M7 and Selected Antibiotics on the Biofilm Formed by Shiga Toxin-Producing <i>Escherichia coli</i>
by: Agnieszka Necel, et al.
Published: (2022)

Distribution of virulence factors, antimicrobial resistance genes and phylogenetic relatedness among Shiga toxin-producing Escherichia coli serogroup O91 from human infections
by: Magdalena Nüesch-Inderbinen, et al.
Published: (2021)

Development of a real-time PCR assay and comparison to CHROMagarTM STEC to screen for Shiga toxin-producing Escherichia coli in stool, Cape Town, South Africa
by: John B. Kalule, et al.
Published: (2017)

Altered Brain Penetration of Diclofenac and Mefenamic Acid, but Not Acetaminophen, in Shiga-Like Toxin II-Treated Mice
by: Masaya Fukuda, et al.
Published: (2005)

Peripheral nervous system manifestations of Shiga toxin-producing E. coli-induced haemolytic uremic syndrome in children
by: Luisa Santangelo, et al.
Published: (2021)

Shiga toxin-associated hemolytic uremic syndrome complicated by intestinal perforation in a child with typical hemolytic uremic syndrome
by: Hye Jin Chang, et al.
Published: (2014)

Molecular Detection of Antibiotic Resistance Genes in Shiga Toxin-Producing <i>E. coli</i> Isolated from Different Sources
by: Momna Rubab, et al.
Published: (2021)

Decrease in Shiga toxin expression using a minimal inhibitory concentration of rifampicin followed by bactericidal gentamicin treatment enhances survival of <it>Escherichia coli </it>O157:H7-infected BALB/c mice
by: Abdelnoor Alexander M, et al.
Published: (2011)

Neglected diseases in the news: a content analysis of recent international media coverage focussing on leishmaniasis and trypanosomiasis.
by: Mangai Balasegaram, et al.
Published: (2008)

The frequency of detection of markers of Сytomegalovirus infection in children with recurrent respiratory diseases in patients with Shiga-toxin-associated hemolytic-uremic syndrome (STEC-HUS)
by: I. B. Repina, et al.
Published: (2021)

Characterization of Lytic Bacteriophages Infecting Multidrug-Resistant Shiga Toxigenic Atypical Escherichia coli O177 Strains Isolated From Cattle Feces
by: Peter Kotsoana Montso, et al.
Published: (2019)

Molecular Detection, Serotyping, and Antibiotic Resistance of Shiga Toxigenic <i>Escherichia coli</i> Isolated from She-Camels and In-Contact Humans in Egypt
by: Mohamed Said Diab, et al.
Published: (2021)

Antibiotic Resistance in Shiga Toxigenic <i>Escherichia coli</i> Isolates from Surface Waters and Sediments in a Mixed Use Urban Agricultural Landscape
by: Yvonne Ma, et al.
Published: (2021)

Development of an enterotoxigenic Escherichia coli vaccine based on the heat-stable toxin
by: Ephrem Debebe Zegeye, et al.
Published: (2019)

Persistence and Culturability of <i>Escherichia coli</i> under Induced Toxin Expression
by: Yousr Dhaouadi, et al.
Published: (2024)

AISLAMIENTO DE ESCHERICHIA COLI PRODUCTORA DE TOXINA SHIGA (STEC) EN HECES DE GANADO Y DETECCIÓN DE FACTORES DE VIRULENCIA ASOCIADOS CON SU PATOGÉNESIS
by: Edwin Quiguanás-Guarín
Published: (2021)

The Effects of Escherichia coli STa (Heat Stable) Toxin on the Contractility of Isolated Human Myometrium In Vitro
by: A. Leal de Carrera, et al.
Published: (1998)